atractylon

01/01/2022 - "The proliferative ability of HepG2 liver cancer cells decreased, whereas the apoptotic rate improved after atractylon treatment. "
01/01/2022 - "The aim of the present study was to investigate the molecular mechanisms of atractylon in the inhibition of invasion and migration of hepatic cancer cells. "
01/01/2022 - "Atractylon was demonstrated to regulate the expression of TMPO‑AS1 and CCDC183‑AS1 and inhibited the invasion and migration of liver cancer cells. "
01/01/2022 - "Molecular mechanism of atractylon in the invasion and migration of hepatic cancer cells based on high‑throughput sequencing."
01/01/2019 - "In addition, atractylon inhibited the growth of hepatic cancer and showed an inhibition effect on EMT process in vivo. "

01/01/2019 - "Methods: In this study, we evaluated the antihepatic cancer (HCC) effect of atractylon in vitro and in vivo and investigated its underlying mechanism. "
01/01/2019 - "The anti-HCC effect of atractylon in vivo was evaluated by a subcutaneous tumor model. "
06/01/1994 - "Atractylodis Rhizoma extract and its component, atractylon, inhibit tumor promotion in mouse skin two-stage carcinogenesis."
06/01/1994 - "Furthermore, atractylon markedly inhibited tumor promotion by TPA following 7,12-dimethylbenz[a]anthracene initiation in mice."
10/01/2016 - "Atractylon treatment at doses of 10‑40 mg/kg for 5 days attenuated influenza A virus (IAV)‑induced pulmonary injury and decreased the serum levels of interleukin (IL)‑6, tumor necrosis factor‑α and IL‑1β, but increased interferon‑β (IFN‑β) levels. "

01/01/2022 - "In the present study, we aimed to evaluate the effects of atractylon on the anti-tumorigenesis properties of GBM. "
06/01/1994 - "Atractylodis Rhizoma extract and its component, atractylon, inhibit tumor promotion in mouse skin two-stage carcinogenesis."
01/01/2022 - "Atractylon inhibits the tumorigenesis of glioblastoma through SIRT3 signaling."

05/31/2022 - "The intestinal cancer HT29 cell lines were cultured in vitro, and atractylon at different concentrations (15 and 30 mg/mL) was added. "
05/31/2022 - "Effects of Atractylon on Proliferation and Apoptosis of Intestinal Cancer Cells Through PI3K/AKT/mTOR Signaling Pathway."
05/31/2022 - "Atractylon at an appropriate concentration can inhibit the proliferation and promote the apoptosis of intestinal cancer cells by suppressing the PI3K/AKT/mTOR signaling pathway, which can be used to treat colorectal cancer and other related diseases."
05/31/2022 - "The study aimed to explore the effects of atractylon on the proliferation and apoptosis of intestinal cancer cells through the phosphatidylinositol 3-hydroxy kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway. "

01/01/2023 - "Expression of Concern: Atractylon treatment prevents sleep-disordered breathing-induced cognitive dysfunction by suppression of chronic intermittent hypoxia-induced M1 microglial activation."
01/01/2020 - "Atractylon treatment prevents sleep-disordered breathing-induced cognitive dysfunction by suppression of chronic intermittent hypoxia-induced M1 microglial activation."